2019 |
Heike Trautmann |
Regulation (EU) 2015/2283 on novel foods - Analysis of the amendments and their impact on regulatory work *** |
|
|
2019 |
Dr. Anja von Au |
Medical device safety reporting in clinical investigations and PMCF studies under the new MDR - A comparison to the current German legislation |
|
|
2019 |
Dr. Oliver Walisko |
Potency Assignment of Factor IX Medicinal Products for the Treatment of Hemophilia B: Regulatory meets Practice *** |
|
|
2019 |
Susanne Werk |
The European MDR and its potential impact on the existing German legislation on medical devices and the status of the discussion on the interpretation of several requirements of the MDR |
|
|
2019 |
Fabian Witzel |
Standardization as Key for Global Digital Health Regulatory Affairs Improvement *** |
|
|
2019 |
Dr. Nicole Woik |
Comparative analysis of the strategies for implementation of the Clinical Trials Regulation (EU) No 536/2014 in Europe *** |
|
|
2019 |
Dr. Daniel Zucker |
Implementation of Regulatory Requirements for Lipid based Excipients - Claims and Reality |
|
|
2018 |
Carlos Canete |
Bacteriophage therapy: an analysis of the European regulatory framework and its proposals for amendment *** |
|
|
2018 |
Lais da Silva |
Critical Assessment - Implementation of ICH Guidelines in Brazil *** |
|
|
2018 |
Sofia Dust |
Impact of China's regulatory reforms on business operations in Chinese pharmaceutical market: Perspectives and Challenges for multinational pharmaceutical companies *** |
|
|
2018 |
Zohaira El Malahi |
Maintenance of Marketing Authorizations of Medicinal Products in the MENA Region – Differences and Similarities to European Procedures *** |
|
|
2018 |
Sebastian Fischer |
The 2017 EC Report on the Paediatric Regulation - A critical analysis of stakeholder positions *** |
|
|
2018 |
Dr. Maxim Frizler |
GVP module V revision 2 a review of recommendations and main changes |
|
|
2018 |
Dr. Karin Geßele |
Regulatory Framework and Challenges for Approval of "Generic" Non-biological Complex Drugs (NBCDs) *** |
|
|
2018 |
Mareike Gleissner |
New Legal Framework for Food for Special Medical Purposes - Implications on Demarcation and Regulatory Requirements at European Level and in Germany *** |
|
|
2018 |
Dr. Florian Haberl |
IDMP - a business driver for implementation of a company wide master data management system in pharmaceutical companies |
|
|
2018 |
Hannah Hähl |
Adaptive Pathways - Challenges of a global development program for early patient access in the context of the current Health Care System and Health Technology Assessment Landscape in Europe, USA and Japan |
|
|
2018 |
Dr. Susan Heller |
Harmonisation of quality dossier following Union Referral - Challenges and points to consider with focus on sterile finished products *** |
|
|
2018 |
Dr. Claudia Heß |
Expectations of eCTD 4.0 - also a step forward for small and medium sized enterprises? *** |
|
|
2018 |
Sylvia Hinderfeld |
Labelling Requirements for Clinical Trials in the EU - Overview of current and future requirements when Regulation (EU) 536/2014 applies *** |
|
|